Exact Mass: 637.1404987999999
Exact Mass Matches: 637.1404987999999
Found 39 metabolites which its exact mass value is equals to given mass value 637.1404987999999,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Anacetrapib
C30H25F10NO3 (637.1674659999999)
Pelargonidin 3-glucoside-5-(6-acetylglucoside)
Luteolinidin 5-(3-glucoside-2-acetylglucoside)
Malvidin 3-O-(6-O-(3-hydroxy-3-methylglutaryl)-beta-glucopyranoside
Anacetrapib
C30H25F10NO3 (637.1674659999999)
D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D000890 - Anti-Infective Agents > D023303 - Oxazolidinones D009676 - Noxae > D000963 - Antimetabolites C471 - Enzyme Inhibitor
2,3,4,6-tetra-o-benzoyl-beta-d-glucopyranosyl isothiocyanate
C35H27NO9S (637.1406452000001)
(S,S)-N-(p-Toluenesulfonyl)-1,2-diphenylethanediamine(chloro)(p-cymene)ruthenium(II)
3-(7-Bromo-9,9-diphenyl-9H-fluoren-2-yl)-9-phenyl-9H-carbazole
2-Oxazolidinone, 5-[3,5-bis(trifluoromethyl)phenyl]-3-[[4-fluoro-2-methoxy-5-(1-methylethyl)-4-(trifluoromethyl)[1,1-biphenyl]-2-yl]methyl]-4-methyl-, (4S,5R)-
C30H25F10NO3 (637.1674659999999)
D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D000890 - Anti-Infective Agents > D023303 - Oxazolidinones D009676 - Noxae > D000963 - Antimetabolites
[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[4-(4-chlorophenyl)-3-cyano-2-oxo-6-pyridin-2-ylpyridin-1-yl]oxan-2-yl]methyl acetate
Delphinidin 3-O-3,6-O-dimalonylglucoside
C27H25O18+ (637.1040849999999)
3-O-sulfonato-beta-D-glucopyranosyluronate-(1->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranose
Akt1-IN-1
Akt1-IN-1 (compound 5b) is a potent and selective Akt1 inhibitor with an IC50 value of 18.79 nM in MIA Paca-2 cells. Akt1-IN-1 does not exhibit obvious teratogenicity, hepatotoxicity and cardiotoxicity (No Observed Adverse Effect Level > 100 μM). Akt1-IN-1 can be used for researching anticancer[1].
(5-carbamimidamido-1-oxo-1-{[1-(sulfooxy)-1-[4-(sulfooxy)-3-[(sulfooxy)methyl]phenyl]propan-2-yl]oxy}pentan-2-yl)trimethylazanium
[C19H33N4O14S3]+ (637.1155338)
10-amino-3-{[(2s,3r,4s,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione
10-amino-3-{[(2s,3r,4s,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione
(2s)-2-carboxy-5-{[(2s,3r,4s,5s,6r)-6-{[(2-carboxyacetyl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-1-{2-[(2s)-2,6-dicarboxy-2,3-dihydro-1h-pyridin-4-ylidene]ethylidene}-6-hydroxy-2,3-dihydro-1h-1λ⁵-indol-1-ylium
10-amino-3-({4,5-dihydroxy-6-methyl-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-15-methyl-18-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1(19),2(7),3,5,9,12,14,16(20)-octaene-8,11,17-trione
5-{[(2s,3s,4s,5s,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-7-hydroxy-2-(4-hydroxyphenyl)-3-{[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1λ⁴-chromen-1-ylium
(2r)-2-amino-3-(4-hydroxyphenyl)-4-oxo-2,3-bis(3,4,5-trihydroxybenzoyl)-4-(3,4,5-trihydroxyphenyl)butanoic acid
C30H23NO15 (637.1067648000001)